---
created: 2025-04-13
updated: 2025-04-13T10:51
id: ukNk`zH,Dk
specialty: nephro
specialty_id: 98
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::05-cardio::08-hypertension::03-antihypertensives
  - source/ak-step1-v11::
  - theme/b&b::19-renal::05-other::03-diuretics
  - source/ak-step1-v11::
  - theme/firstaid::14-renal::05-pharm::04-loop-diuretics
  - source/ak-step1-v11::
  - source/ome-banner::clinical::01-cardiology::08-hypertension
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::06-renal::03-loop-diuretics-&-ethacrynic-acid
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::17-renal::loop-diuretics-(furosemide,-bumetanide,-torsemide)
  - source/ak-step1-v11::
  - theme/sketchypharm::02-cardio-&-renal::02-diuretics::02-loop-diuretics
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary
  - source/ak-step1-v11::^systems::renal::pharmacology"
type: flashcard
---

# Question
Decreased medullary hypertonicity (e.g. due to loop diuretics) results in an inability to **concentrate** urine

---

# Answer
